GLP-1 Medicine After Weight-Loss Surgery in Chinese Patients
Part of Hormones & metabolism clinical trials.
This trial tests whether adding a GLP-1 medication (a type of diabetes and weight-loss drug) after weight-loss surgery helps patients with obesity and related health conditions like diabetes. Researchers want to see if combining surgery with this medicine works better than surgery alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are planning to have or have just had sleeve gastrectomy (a weight-loss surgery that reduces stomach size)
- Your BMI is 30 or higher, meaning you meet medical criteria for obesity
- You have been diagnosed with metabolic syndrome or type 2 diabetes
- You are between 18 and 60 years old
- You have not taken GLP-1 medicines (like semaglutide, tirzepatide) in the past 6 months
- You have never had any previous weight-loss or metabolic surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a GLP-1 receptor agonist (a medication that helps control blood sugar and appetite) after weight loss surgery improves outcomes for people with severe obesity and related health problems like type 2 diabetes.
This study tests if adding a GLP-1 medication to weight-loss surgery helps people with obesity and related conditions like diabetes. It may improve weight loss and blood sugar control more than surgery alone.
This study looks at how taking a GLP-1 medicine (like Ozempic or Wegovy) affects your fat tissue before bariatric surgery. It compares people who have taken a GLP-1 for at least 3 months to those who never have.
This study tests whether switching to an oral weight-loss medication can help you keep off the weight you lost after stopping a GLP-1 injection like semaglutide or tirzepatide. You might qualify if you live in Massachusetts, are between 18 and 80, have a BMI of 30 or higher, lost at least 10% of your body weight on these injections, and are willing to be randomly assigned to a new treatment.
This trial is for people who had metabolic surgery 6 months ago and still have a BMI of 28 or higher. It tests whether an anti-obesity medication can help with further weight loss after surgery.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.